 MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
Director, Case CCC
NCI Webinar: The Cancer Genome Atlas (TCGA) Program
The NCI Office of Cancer Centers is hosting a series of free webinars that I hope you will participate in. The next webinar will be Tuesday, November 1, 2-3:30 pm, and will highlight The Cancer Genome Atlas (TCGA) program, and Dr. Jill Barnholtz-Sloan will be one of the featured presenters. Drs. Barnholtz Sloan and Donna Hansel have grants supporting contributions to the TCGA in brain tumors and bladder cancer.
CASE CCC IN THE NEWS
Sectra Signs Medical Imaging Research Agreement With University
Sacramento Bee - Oct 25, 2011
... with centralized archiving," says Pablo R. Ros, MD, Theodore J. Castele University Professor and Chairman, University Hospitals Case Medical Center. ...
Sharp Tomosynthesis Technology May Catch Breast Cancer Earlier
Oncology Nurse Advisor - Oct 25, 2011
... when it is treatable," explained Donna Plecha, MD, director of breast imaging at the medical center, in a statement issued by UH Case Medical Center. ...
MARK YOUR CALENDARS
Cancer Center Seminar Series: SNP's: Activity or Toxicity of Targeted Agents in Renal Cancer!
Friday, November 4
12-1 pm
Frohring Auditorium - BRB 105
Please join us Friday, November 4 at the next Cancer Center Seminar Series featuring Drs. Brian Rini and Ram Ganapathi, who will present SNP's: Activity or Toxicity of Targeted Agents in Renal Cancer!.
Graft vs. Host Disease Conference
The Case CCC and the Meredith A. Cowden Foundation are bringing a national educational conference on Graft vs. Host Disease (GvHD) to Cleveland on this Friday, November 4, 7:30 am to 5 pm, at the Renaissance Cleveland Hotel. The conference will unite leading specialists in hematology, oncology, bone marrow transplantation and immunology from more than a dozen of the nation's top cancer research centers and educational institutions to present information on cutting-edge research and treatments. Registration (includes CME credits), is $100 for physicians and pharmacists, $75 for nurses and other healthcare professionals and $25 for students. Please make every effort to register and attend.
NCRM Annual Scientific Retreat
The National Center for Regenerative Medicine (NCRM) Annual Scientific Retreat will be Monday, November 14 from 8 am-4:30 pm in Dively 202. Anyone within the CWRU community with an interest in regenerative medicine is encouraged to attend, including faculty, researchers, postdocs, graduate and undergraduate students, lab staff, and clinicians. The day will include a scientific poster session. Cash prizes will be awarded for top posters submitted by graduate students and postdocs. Please send poster title and abstract to Susan Halloway. There is no fee to attend, but registration is required.
FUNDING OPPORTUNITIES
Cellular Molecular Imaging of Cancer Pilot Funding: Cancer Microenvironment
The Case CCC is providing seed funding to develop a strong set of integrative cancer biology–molecular imaging projects that enhance interactions between clinical and basic science researchers with members of the Cancer Imaging Program. This funding will support investigative interdisciplinary teams with broad expertise in cancer biology, imaging science, pharmacology, or genetics with opportunities to explore aspects of cancer biology with non-invasive imaging technologies. Open to all Case, CCF and affiliate faculty members with a cancer or molecular imaging research track record.
See the RFA for more information.
Deadline Extended: November 17
SU2C-PCF Prostate Dream Team Translational Cancer Research Grant
Stand Up To Cancer and the Prostate Cancer Foundation, along with the American Association for Cancer Research, call upon the cancer research community to submit letters of intent for a new Dream Team dedicated to prostate cancer research. You are invited to submit ideas for translational cancer research projects that would address therapeutic interventions for advanced prostate cancer with special emphasis on metastatic disease, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators.
LOI Deadline: November 28
CTSC Core Utilization Funding Opportunity
The Clinical and Translational Science Collaborative (CTSC) of CWRU Core Utilization pilot program supports investigator use of and familiarity with CTSC Core operations and personnel, in anticipation of applications for external funding using CTSC resources. Ideal uses may be to run tests on samples already collected, build cross-disciplinary collaborative programs, develop enabling technologies, new therapeutic, diagnostic or outcomes assessment approaches and/or devices; basic researcher/clinical researcher collaborations; and/or promotion of research in the community.
Deadline: December 1
Innovations for Health: Solutions that Cross Borders
The Pioneer Portfolio at the Robert Wood Johnson Foundation (RWJF) is partnering with Ashoka Changemakers to launch Innovations for Health: Solutions that Cross Borders, a competition to find cutting-edge health care solutions from anywhere in the world that have the potential to be applied in other countries. Entries received before December 12 at 5 pm are eligible to win $500 and a private consulting session with industry experts.
Deadline: February 13, 2012
Case CCC Clinical Trials Funding Opportunity
The Case CCC is encouraging investigators to submit Letters of Intent for the Protocol Specific Research Support (PSRS) funding for Year 2011.
The budgeted funds are for the conduct of early phase clinical trials which are testing a candidate agent or device and are of short duration. PSRS funding is restricted to support research nurses and data managers directly involved in the conduct of these clinical trials. Trials which are receiving a partial support from industry are eligible for PSRS funding; however, trials receiving support through other peer reviewed research grants or contracts are not. Currently open to accrual studies which meet the referenced criteria will be considered as well.
Please direct questions to Dr. Smitha Krishnamurthi or Dr. John Sweetenham.
ANNOUNCEMENTS
Chance Named as CWRU SOM Vice Dean of Research
Congratulations to Dr. Mark Chance, who was recently appointed Vice Dean for Research at the CWRU School of Medicine. Dr. Chance is a demonstrated leader in his field, and has served as Director of the Case Center for Proteomics and Bioinformatics since 2005.
Barnholtz-Sloan and Kim Manuscripts Included in Melanoma Supplement
Drs. Jill Barnholtz-Sloan and Julian Kim were co-authors on three manuscripts included in Melanoma Surveillance in the United States, a supplement to the "Journal of the American Academy of Dermatology":
Comprised of 15 manuscripts, the supplement represents the largest, most comprehensive examination of melanoma data to-date covering up to 78% of the US population.
Pilot Project Awards: Interinstitutional Basic, Clinical and Translational Research Projects in Cancer
The following projects have been selected by the Case CCC to receive pilot funding to support Interinstitutional Basic, Clinical and Translational Research Projects in Cancer:
- Drs. William Schiemann and Khalid Sossey-Alaoui: Developing Novel miR-based Chemotherapeutics and Diagnostic Platforms for Triple-negative Breast Cancers
- Drs. David Wald and Ram Ganapathi: Development of a Novel Targeted Regimen for AML
- Drs. Stathis Karathanasis and Vinod Labhasetwar: Image-guided Delivery of Chemotherapeutics from a Nanochain with Tunable Release
- Drs. George Stark and Mark Jackson: Novel Roles of STATS and Interferons in the Generation of Breast Cancer Stem Cells
The purpose of these awards is to foster collaborations and to promote and increase institution-wide capacity and competitiveness in basic, clinical or translational research that is aligned with the Cancer Center Scientific Programs and that spans the institutions of the Case CCC.
Clinical Research Education Needs Assessment Survey
CWRU, Cleveland Clinic, UH and MetroHealth Medical Center have partnered to form the Clinical and Translational Science Collaborative (CTSC). One of the goals of the CTSC is to strengthen the training and career pathways for all clinical and translational research team members, including research assistants, study coordinators, data managers, and study recruiters. The CTSC asks that you participate in a survey to assess interest in a certificate program in clinical research fundamentals. A certificate would demonstrate standard competency among the partner institutions. All responses will be anonymous; candid comments are welcome. The survey will be active through November 18.
|
EVENTS
**All events are open to anyone interested in attending
October 31
Physiology and Biophysics Seminar
Henk L. Granzier, PhD
Professor of Molecular and Cellular Biology, Physiology, and Biomedical Engineering
Norville Endowed Chair, Molecular Cardiovascular Research Program
University of Arizona
Topic: Role of Titin in Muscle Function and Disease
4 pm SOM E501
November 1
Coulter Legacy Lecture
Sue Van
President, Wallace H. Coulter Foundation
Topic: Legacy of Wallace H. Coulter and His Influence on Entrepreneurism
10:45 am WRB 1-413
Cancer Biology Fellows Seminar
Kamini Singh, PhD
Research Fellow, Almasan Lab
Cleveland Clinic
Topic: Role of Autophagy in Prostate Cancer Therapy
AND
Sayer Rashed Al-Harbi
Graduate Student, Almasan Lab
Cleveland Clinic
Topic: The Role of Bcl-2 Family in the Clinical Response of Chronic Lymphocytic Leukemia
11 am NC1-202
Ecker Lecture
Diane Mathis, PhD
Professor, Microbiology and Immunology
Harvard University
Topic Aire Control of Immunological Tolerance: From a Human Disease to a Molecular Mechanism
12 pm BRB 105
November 2
Hematology and Oncology Division Research Conference
Joseph Gibbons, MD
Assistant Professor, Div. of Hem/Onc
CWRU/UH
Topic: IRB Review Changes at the Case Comprehensive Cancer Center
8 am Lerner B-151
Immunology Students/Fellows Research in Progress Seminar Series
Anabelle Visperas
Graduate Student, Min Lab
Cleveland Clinic
Topic: Gamma Delta T cells and Th17 Immunity
AND
Anton Gorbachev, PhD
Research Associate, Fairchild Lab
Cleveland Clinic
Topic: Distinct Roles of CXCR3 Ligands CXCL9 and CXCL10 in the Suppression of Cutaneous Tumor Growth
12 pm NC1-202 Cleveland Clinic
November 3
Molecular and Microbiology Seminar
Piet de Boer, PhD
Professor, Molecular Biology and Microbiology
CWRU
Topic: Cell Division and Cell Shape Determination in E coli
AND
Bing Liu
de Boer Lab, Molecular Biology and Microbiology
CWRU
Topic: Roles of FtsN and Other SPOR-domain Proteins in E coli Cell Division
1 pm SOM W203
November 4
Graft Versus Host Disease Conference
7:30 am - 5 pm Renaissance Cleveland Hotel
Registration required
Hematology/Oncology Fellows Conference
Topic: TBD
8 am Wearn 137
Taussig Cancer Institute Grand Rounds
Gail Roboz, MD
Associate Professor, Medicine
Director, Leukemia Program
Cornell University/ New York-Presbyterian Hospital
Topic: AML 2011
8 am R3/002-003 Cleveland Clinic
Cancer Center Seminar Series
Brian Rini, MD
Associate Professor, Hematology & Medical Oncology
CWRU/Cleveland Clinic
AND
Ram Ganapathi, PhD
Professor, Hematology & Medical Oncology
CWRU/ Cleveland Clinic
Topic: SNP's: Activity or Toxicity of Targeted Agents in Renal Cancer!
12 pm BRB 105
Cancer Center Research in Progress Seminar
Kristy Miskimen, PhD
Postdoctoral Scholar, Jackson Lab
CWRU/UH
Topic: The FAM83 Family of Oncogenes: Similar, Yet Non-Redundant Roles in Tumorigenesis
4 pm WRB 3-136
Case CCC Calendar
LRI Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
ADDITIONAL UPCOMING SEMINARS & EVENTS
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
November 10-12
InterContinental Hotel Cleveland
Details
|
